Skip to content Skip to footer

International Cannabis Weekly: 324

November 10, 2023

Highlights

Share this story
Highlights

UP TO US$770 MILLION TO BE SPENT ON CANNABIS TESTING PER YEAR BY 2027

A new report, The Cannabis Testing Report from Prohibition Partners, offers comprehensive and invaluable insights into the critical aspect of cannabis testing.

READ MORE  »

PORTUGAL POISED TO BE MAJOR MEDICINAL CANNABIS PRODUCER

READ MORE »

OHIO BECOMES 24TH US STATE TO LEGALISE CANNABIS FOR RECREATIONAL PURPOSES

READ MORE »

Highlights

Share this story
Europe

Highlights

Share this story
Stocks

Highlights

Share this story
United States

Highlights

Share this story
Upcoming Event

Highlights

Share this story
Canada

Highlights

Share this story
Upcoming Event

Highlights

Share this story
LATAM & The Caribbean
  • Brazil’s cannabis market could generate around R$700 million in 2023, according to a study.
  • Brazilian compounding pharmacy faces legal battle after court bans compounding formulas with cannabis derivatives.
  • Argentina’s 420 CBD Premium completes the country’s first export of cannabis beauty products.
  • British Columbia’s Allied Corp. exports THC based medical cannabis flower from Colombia to Australia.

Highlights

Share this story
APAC
  •  Cannabis set for a resurge in Japan thanks to growers seeking to revitalise production.
  • Australia’s Bod Science announces details of A$2 million capital raise, while implementing cost-cutting measures.
  •  Health House International (HHI) founder ‘back in the pharmacy game’ having opened Plant Pharm in Perth.
  • Medicinal cannabis prescriptions in Australia reach second highest total of the year.

Highlights

Share this story
Africa & The Middle East
  • Medical cannabis prescriptions rise in Israel during war with Hamas as patients seek relief from PTSD and pain.
  • Ball in motion as portfolio committee approves cannabis for private purposes bill in South Africa.
Latest Issues

Insights

on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.